A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
Clinical trial NCT00909597 · COMPLETED
Trial details
- NCT number
- NCT00909597
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2010-11-01
- Enrollment
- 756
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.